Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by ALVOGEN MALTA
FDA Drug Application 018240 by ALVOGEN MALTA
Application Number
018240
Application Type
New Drug Application
Sponsor Applicant
ALVOGEN MALTA
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New molecular entity (NME)
Therapeutic Potential
Standard
Orphan Code
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
8/19/1981
N
AP
0
9/23/1981
SLR
AP
0
9/4/1985
SE1
AP
0
4/7/1983
SCF
AP
0
9/27/1983
SCP
AP
0
9/13/1989
SE1
AP
0
12/15/1983
SCS
AP
0
7/12/1984
SCM
AP
0
11/19/1984
SCS
AP
0
9/18/1985
SLR
AP
0
2/13/1987
SCP
AP
0
4/9/1990
SE2
AP
0
2/21/1991
SLR
AP
0
2/21/1991
SLR
AP
0
2/21/1991
SLR
AP
0
9/18/1991
SLR
AP
0
8/5/1992
SLR
AP
0
8/5/1992
SLR
AP
0
4/29/1993
SLR
AP
0
5/4/1994
SLR
AP
0
2/9/1996
SLR
AP
0
10/11/1996
SCP
AP
0
4/4/2000
SLR
3834
025
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/18240-s025_Tenormin.pdf
6/4/2001
AP
0
7/21/1999
SLR
3831
026
http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/18240-s026_tenormin.pdf
6/4/2001
AP
0
1/9/2003
SLR
3929
027
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/18240slr027ltr.pdf
1/9/2003
AP
0
11/6/2003
SLR
6902
028
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/18240slr028,19058slr016ltr.pdf
11/13/2003
AP
0
2/9/2005
SLR
11102
029
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/18240s029ltr.pdf
2/11/2005
AP
0
4/29/2008
SLR
19758
030
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/018240s030ltr.pdf
5/5/2008
AP
0
8/17/2011
SLR
29822
031
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/018240s031ltr.pdf
8/18/2011
AP
0
8/17/2011
SLR
29870
031
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018240s031lbl.pdf
8/24/2011
AP
0
10/31/2012
SLR
34238
032
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/018240Orig1s032ltr.pdf
11/5/2012
AP
0
10/31/2012
SLR
34292
032
http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018240s032lbl.pdf
11/6/2012
AP
0
7/9/2015
SCM
AP
0
7/15/2015
SCM
AP
0
7/16/2015
SCM
AP
0
8/27/2015
SCM
AP
0
9/3/2015
SCM
AP
0
9/10/2015
SCM
Back to FDA Applications sponsored by ALVOGEN MALTA